Geistlich Ortho

Geistlich Ortho Geistlich is specialised in biomaterials for the regeneration of bone and cartilage.

Geistlich is ready for Freiburgeknorpeltage 2026!Meet us at our booth to explore how our solutions contribute to better ...
20/01/2026

Geistlich is ready for Freiburgeknorpeltage 2026!

Meet us at our booth to explore how our solutions contribute to better patient care in sports medicine.

📍 Freiburg (DE) | 🗓️ 23 – 24 January 2026

👥 Our team represented by Steven Kramer, Lukas Allamand, Evelyne Hasler, Andrea Raser, Michael Uffelmann will be happy to connect with you.

Don’t miss our lunch symposium on the topic "Regenerieren statt ersetzen: Fortschritte in der biologischen Gelenktherapie", organized in cooperation with the company RegenLab:

🏛️ Room K2-4
📅 Date 23.01.2026
⏰ Time 12:45–13:45

Let’s exchange ideas and shape the future of joint preservation together!

🌟 Major Milestone for biologic cartilage regeneration in Austria: LKF Code for one step matrix assisted cartilage repair...
19/01/2026

🌟 Major Milestone for biologic cartilage regeneration in Austria: LKF Code for one step matrix assisted cartilage repair using AMIC Chondro-Gide® 🌟

As of January 1st, the procedure “Single stage, matrix assisted cartilage repair of the knee joint (arthroscopic)” has been introduced as a new service item in the Austrian LKF catalogue. It is now assigned to the corresponding case based reimbursement categories in both the inpatient and outpatient LKF models.

✅ LKF Code: NF126
✅ LKF Points: 4,931

This development supports the routine and reimbursable use of Geistlich’s AMIC® Chondro Gide® procedure in arthroscopic knee surgery, providing clear medical and economic framework conditions for clinical practice.

It enables
• Integration of biological, single stage matrix assisted cartilage procedure into everyday practice
• Improved planning and reimbursement clarity
• Structured coding for consistent clinical workflows

This outstanding step was achieved through an initiative of the Austrian Expert Group on Joint Preservation and Cartilage Regeneration, and the QKG | Gesellschaft für Knorpelregeneration und Gelenkerhalt in coordination with the Solve Consulting Company of BMI.

📘 If you would like to know more about the correct indications, you can download the Austrian guidelines on cartilage therapy free of charge here:

👉https://www.oegout.at/wp-content/uploads/2025/08/Empfehlungen-des-Expertenkreis-Gelenkserhalt-und-Knorpelregeneration-Oesterreich-zur-Behandlung-von-Knorpelschaeden-am-Kniegelenk_2025_version-3.pdf

Happy New Year!2026 is here—a year full of opportunities to connect, share expertise, and advance cartilage regeneration...
06/01/2026

Happy New Year!

2026 is here—a year full of opportunities to connect, share expertise, and advance cartilage regeneration together.

At Geistlich, this year we look forward to engaging with you through:

• International Congresses - Come and meet us at our booth and attend our Corporate Symposia to exchange insights and clinical experience.

• Partnering Events – Join exclusive training sessions organized by leading societies, where Geistlich contributes as a partner to foster knowledge exchange and surgical skills development.

• Geistlich Medical Education – By attending our specialized training programs, you can take your surgical skills and expertise to the next level and ensure the highest standard of care for your patients.

Let’s make 2026 a year of collaboration, continuous education, and shaping the future of regeneration—together!

You can find all details about our presence at congresses, partnering events, and courses through this link:
https://www.geistlich.com/orthopedic/courses-and-congresses-orthopedic

Only a few days to go until the next EFAS Skills Course in Augsburg📍  University Hospital Augsburg, Stenglinstraße 2, Al...
09/12/2025

Only a few days to go until the next EFAS Skills Course in Augsburg

📍 University Hospital Augsburg, Stenglinstraße 2, Allemagne, 86156, Germany
📅 13–14 December 2025

Geistlich will be present as a partner, with Steven Kramer and Michael Uffelmann attending the event.

We’re looking forward to a high-level course on Hindfoot — with engaging theoretical and practical sessions led by an international faculty.

🔗https://www.efas.net/members/events-area/eventid/133/e/efas-hindfoot-13-dec-2025

Live AMIC Surgery at AO Davos Courses - What an incredible experience at one of the world’s premier educational events i...
02/12/2025

Live AMIC Surgery at AO Davos Courses - What an incredible experience at one of the world’s premier educational events in Davos!

At the AO Sports Courses 2025, Geistlich Ortho proudly hosted a live surgery demonstration of the AMIC® procedure for treating bifocal cartilage lesions in the knee.
The technique was performed in the impressive Rimasys mobile operating theatre by two renowned experts:
Prof. Dr. med. univ. Elmar Herbst and Prof. Dr. med. Christoph Kittl from Münster University Hospital (GER).

👉 Interested in learning more about single-stage cartilage treatment?
📩 Contact us – we are happy to support your cases and share our hashtag

AO Davos Courses: An environment where education, innovation, and collaboration come together to advance patient care.



⛷️ Will you be attending the AO Sports Advanced Course on Knee Injuries and Deformities in Davos from November 30 to Dec...
27/11/2025

⛷️ Will you be attending the AO Sports Advanced Course on Knee Injuries and Deformities in Davos from November 30 to December 3, 2025?

👉 Join the industry-sponsored lunch session in the SHARD
🗓️ Monday, December 1, 2025 | 12:30 – 13:05

🎥 Prof. Dr. med. univ. Elmar Herbst, PhD and Prof. Dr. med. Christoph Kittl MD(Res) will demonstrate the well-established AMIC® technique for bifocal, full-thickness cartilage lesions in the knee — combining science, clinical outcomes, and practical expertise.

This session offers a unique mix of science and practice: you will have the opportunity to watch live how the experts share key practical insights during the surgical demonstration at the specimen

🤝 The Geistlich Ortho team — David Wemans, Evelyne Hasler, Laura Prospero, and Matthias Dunkel — looks forward to meeting you in Davos!

Geistlich is proud to be a partner in this course organized by the internationally recognized AO Foundation, which focuses on a comprehensive approach to knee surgery — combining clinical decision-making, surgical techniques, and hands-on training for managing complex knee disorders.



Only a few days to go until the next EFAS Skills Course in Krakow!📍 Krakow 📅 14–15 November 2025Geistlich will be presen...
12/11/2025

Only a few days to go until the next EFAS Skills Course in Krakow!

📍 Krakow
📅 14–15 November 2025

Geistlich will be present as a partner, with our colleague Arpad Kassa attending the event.

We’re looking forward to a high-level course on tendon, ligament, and cartilage surgery — with engaging theoretical and practical sessions led by an international faculty.

🔗 https://tinyurl.com/48739j85


An inspiring day at the IBRA Master Course in Basel! ✨A big thank you to the IBRA Institute for the outstanding collabor...
07/11/2025

An inspiring day at the IBRA Master Course in Basel! ✨

A big thank you to the IBRA Institute for the outstanding collaboration and the excellent, well-organized IBRA Master Course “Challenges in Foot and Ankle Surgery”. 🙌

Special thanks to the Chairman Victor Valderrabano and to all the faculty for the excellent topics covered, the interesting case presentations, and the nice discussions that made the day really engaging. 💬

Among the many insightful topics discussed, it was great to see the Geistlich Chondrogide Membrane included in the context of foot and ankle surgery.

Events like this continue to push the boundaries of innovation and excellence in surgical education. 👏

Geistlich is proud to be a partner of the IBRA Master Course: Challenges in Foot & Ankle Surgery!📍 Basel | November 7–8,...
20/10/2025

Geistlich is proud to be a partner of the IBRA Master Course: Challenges in Foot & Ankle Surgery!

📍 Basel | November 7–8, 2025

Hosted at the IBRA Institute, this advanced two-day course—led by Prof. Dr. med. Dr. phil Victor Valderrabano and an international faculty—combines in-depth theory with hands-on training, featuring expert-led discussions and practical exercises for a comprehensive learning experience.

✅ For detailed information and registration, please visit:
🔗 https://www.ibra.net/events/$/Challenges-in-Foot-Ankle-Surgery/620

🚨 Exciting Clinical Milestone🦵 OrthoPure®XT from Tissue Regenix Group is a safe, off-the-shelf product in ACL Reconstruc...
02/10/2025

🚨 Exciting Clinical Milestone

🦵 OrthoPure®XT from Tissue Regenix Group is a safe, off-the-shelf product in ACL Reconstruction!

The first-in-human 5-year clinical study of a novel porcine xenograft for ACL reconstruction has just been published in the Journal of Experimental Orthopaedics.

✅ Key Highlights:
- 40 patients treated with a decellularized porcine tendon graft
- No immunogenic response observed
- Clinical outcomes comparable to autografts and allografts
- Graft ruptures limited to young male patients
- MRI and radiographic results support safety and performance

This study marks a significant step forward in expanding graft options for ACL surgery, offering a biomechanically sound and immunologically safe alternative.

📄 Read the full publication in our bio!

Contact us for more information ➡️ gpag.ortho@geistlich.ch

Cartilage Image of the month – September 2025 🍁🍂🖼️ Selected as the Cartilage Image of the Month September, this case was...
29/09/2025

Cartilage Image of the month – September 2025 🍁🍂

🖼️ Selected as the Cartilage Image of the Month September, this case was submitted by Dr. Andrejs Finogejevs (LV).
A 42-year-old active female office worker presented with pain, stiffness, and limited knee motion for two months (VAS 4–6). Conservative treatment included NSAIDs and a knee brace. Imaging revealed a 1.5 x 2.5 cm cartilage defect on the medial femoral condyle.

Dr. Finogejevs performed a mini-open chondroplasty and microfracture. At 6 months post-op, the patient reported no pain, had returned to sports activities, and was fully weight-bearing without crutches.

At 6 months post-op, the patient was pain-free, active in sports, and walking without crutches. The one-year follow-up image shows a well-filled defect, with cartilage regeneration reaching the level of the surrounding tissue—indicating a successful outcome and excellent tissue remodeling.

Mark your calendars! 📅On 1 July, the 𝗔𝗚𝗔𝗻𝘆𝘄𝗵𝗲𝗿𝗲 𝗥𝗼𝗮𝗱𝟮𝗛𝗮𝗺𝗯𝘂𝗿𝗴 kicks off with “Move on: Patellaluxation” – an interactive ...
25/06/2025

Mark your calendars! 📅

On 1 July, the 𝗔𝗚𝗔𝗻𝘆𝘄𝗵𝗲𝗿𝗲 𝗥𝗼𝗮𝗱𝟮𝗛𝗮𝗺𝗯𝘂𝗿𝗴 kicks off with “Move on: Patellaluxation” – an interactive online event by Winglet Community 🦵

We’re proud to support this exciting stop on the road to the AGA Congress in Hamburg!

🎟 Free registration & full details via

Adresse

Bahnhofstrasse 40
Wolhusen

Öffnungszeiten

Montag 08:00 - 12:00
13:00 - 17:00
Dienstag 08:00 - 12:00
13:00 - 17:00
Mittwoch 08:00 - 12:00
13:00 - 17:00
Donnerstag 08:00 - 12:00
13:00 - 17:00
Freitag 08:00 - 12:00
13:00 - 17:00

Telefon

+41414925555

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von Geistlich Ortho erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.

Die Praxis Kontaktieren

Nachricht an Geistlich Ortho senden:

Teilen

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

About us

Geistlich Surgery produces innovative bio-derived matrix products for bone and cartilage, including Orthoss®, Orthoss Collagen®, and Chondro-Gide®. Our products leverage the body’s own healing potential to regenerate bone and cartilage. Our focus is on helping people maintain and regain their quality of life.

Geistlich Surgery is a business unit of Geistlich Pharma AG, which is headquartered in Switzerland. Entirely family owned since 1851, the company develops, produces, and markets medical devices for regenerative medicine and pharmaceuticals. From research and development to marketing, our operations are fully integrated under one roof, which enables us to oversee and optimize all levels of our business.